Immunotherapy in gynecological oncology [Immuntherapie in der gynäkologischen onkologie]

被引:0
|
作者
Reinartz S. [1 ]
Wagner U. [1 ,2 ]
机构
[1] Klinik für Gynäkologie, Gynäkologische Endokrinologie und Onkologie, Universitätsklinikum Gießen und Marburg
[2] Klinik für Gynäkologie, Gynäkologische Endokrinologie und Onkologie, Universitätsklinikum Gießen und Marburg, 35037 Marburg
来源
Der Gynäkologe | 2006年 / 39卷 / 2期
关键词
Antibody; Dendritic cells; Immunosuppression; Immunotherapy; Vaccine;
D O I
10.1007/s00129-005-1796-8
中图分类号
学科分类号
摘要
Given the limits of conventional therapeutic regimens, there is an urgent need to investigate alternative treatment approaches for the improvement of quality of life in patients with gynecological tumors. An attractive option is to engage the patient's own immune system to eradicate tumor cells and to induce immunological memory mechanisms, which efficiently prevent the development of new tumors. The considerable progress made in molecular immunology has led to an ongoing search for new strategies in tumor vaccination. The results of clinical studies generally show the immune activity and safety of various tumor vaccines, although until now potent clinical success is missing. However, the identification of crucial weak points in current concepts opens new pathways for combinatory therapy modalities simultaneously affecting different steps of host-tumor interactions. © Springer Medizin Verlag 2006.
引用
收藏
页码:158 / 164
页数:6
相关论文
共 50 条